India · Delayed Price · Currency is INR Park Medi World Statistics
Total Valuation
Park Medi World has a market cap or net worth of INR 118.59 billion. The enterprise value is 118.74 billion.
| Market Cap | 118.59B |
| Enterprise Value | 118.74B |
Important Dates
The last earnings date was Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 431.93M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.69% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 83.33% |
| Owned by Institutions (%) | 11.12% |
| Float | 72.00M |
Valuation Ratios
The trailing PE ratio is 41.96 and the forward PE ratio is 31.97.
| PE Ratio | 41.96 |
| Forward PE | 31.97 |
| PS Ratio | 6.75 |
| PB Ratio | 5.64 |
| P/TBV Ratio | 7.27 |
| P/FCF Ratio | 56.63 |
| P/OCF Ratio | 36.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.59, with an EV/FCF ratio of 56.70.
| EV / Earnings | 42.01 |
| EV / Sales | 6.76 |
| EV / EBITDA | 25.59 |
| EV / EBIT | 29.76 |
| EV / FCF | 56.70 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.74 |
| Interest Coverage | 7.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.38% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.97M |
| Profits Per Employee | 478,166 |
| Employee Count | 5,911 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Park Medi World has paid 811.25 million in taxes.
| Income Tax | 811.25M |
| Effective Tax Rate | 21.47% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 282.17 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 44.42 |
| Average Volume (20 Days) | 50,934 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Park Medi World had revenue of INR 17.56 billion and earned 2.83 billion in profits. Earnings per share was 7.23.
| Revenue | 17.56B |
| Gross Profit | 11.15B |
| Operating Income | 3.99B |
| Pretax Income | 3.78B |
| Net Income | 2.83B |
| EBITDA | 4.64B |
| EBIT | 3.99B |
| Earnings Per Share (EPS) | 7.23 |
Balance Sheet
The company has 4.31 billion in cash and 3.64 billion in debt, with a net cash position of 672.00 million.
| Cash & Cash Equivalents | 4.31B |
| Total Debt | 3.64B |
| Net Cash | 672.00M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 21.04B |
| Book Value Per Share | 50.79 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 3.29 billion and capital expenditures -1.20 billion, giving a free cash flow of 2.09 billion.
| Operating Cash Flow | 3.29B |
| Capital Expenditures | -1.20B |
| Depreciation & Amortization | 651.35M |
| Net Borrowing | -5.38B |
| Free Cash Flow | 2.09B |
| FCF Per Share | n/a |
Margins
Gross margin is 63.50%, with operating and profit margins of 22.72% and 16.09%.
| Gross Margin | 63.50% |
| Operating Margin | 22.72% |
| Pretax Margin | 21.51% |
| Profit Margin | 16.09% |
| EBITDA Margin | 26.43% |
| EBIT Margin | 22.72% |
| FCF Margin | 12.47% |
Dividends & Yields
Park Medi World does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.69% |
| Shareholder Yield | -4.69% |
| Earnings Yield | 2.38% |
| FCF Yield | 1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Park Medi World is 362.50, which is 31.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 362.50 |
| Price Target Difference | 31.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 30.37% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |